Cerebral Palsy Infantile
Conditions
Brief summary
Cerebral Palsy is the most common cause of motor disability in children. It can lead to a deficit of the upper limb which alters the realization of daily activities, in particular in bimanual situations, and eventually leads to a decrease in their participation. Three-dimensional (3D) movement analysis is a tool that provides an accurate and objective measurement of movement. This technology allows us to understand and characterize movement anomalies in order to guide and adapt therapies to the upper limb. The majority of 3D upper limb analysis protocols used to measure the effect of interventions, such as botulinum toxin injections indicated for the treatment of spasticity or other innovative rehabilitative therapies, are unimanual and do not study bimanual function, which is more representative of the actual use of the upper limbs in daily life. Recently, a 3D bimanual analysis protocol called Be An Airplane Pilot (BE-API), taking place in an innovative play context, has been developed and validated in PC children. The 2nd version of the protocol (BE API 2.0) also allowed the exploration of new parameters in a bimanual situation such as the fluidity and the trajectory of the movement. In order to determine the interest of the BE API 2.0 protocol in routine clinical evaluation of the upper limbs, its sensitivity to change, i.e. its capacity to detect modifications caused by a therapy on the movements of the upper limbs is necessary (e.g.: Hand and Arm Bimanual Intensive Therapy Including Lower Extremity (HABIT ILE), botulinum toxin injections).
Interventions
PROCEDUREHABIT ILE rehabilitation course
The HABIT-ILE course, created by the Belgian team of Prof. Yannick Bleyenheuft, is a rehabilitation of the upper and lower limbs, following the concepts of structured motor learning and intensive therapy. The internships last 2 weeks and are performed on a multi-year basis since 2018 at the SSR pediatric, Fondation Ildys, Site de Ty Yann in Brest. In this group, upper limb assessments are performed the week before and the week after the HABIT ILE training course
PROCEDUREbotulinum toxin injections
Toxin injections are used for their effect on the local reduction of spasticity after intramuscular injection. This treatment is usually offered to these children every 6 months or so for functional improvement. These botulinum toxin injections are organized on a weekly basis in a pediatric day hospital (CHU Morvan in Brest). In this group, upper limb assessments were performed 0-2 weeks before and then 4 to 6 weeks after the botulinum toxin injections (see table below), at the peak of the toxin's efficacy.
Sponsors
University Hospital, Brest
Study design
Observational model
COHORT
Time perspective
RETROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
5 Years to 18 Years
Healthy volunteers
No
Inclusion criteria
* Child between the ages of 5 and 18, * Child with cerebral palsy as defined by the CSEP * Level of manipulation sufficient to perform the tasks of the 3D protocol (MACS score I to III included), * For whom the HABIT-ILE therapeutic program and/or botulinum toxin injection is prescribed * Affiliated via his/her parents to a social security plan, * No opposition formulated by the holders of parental authority and the child
Exclusion criteria
* Child with unilateral or bilateral spastic cerebral palsy * Cognitive deficits hindering the comprehension of instructions or visual disorders not allowing the visualization of the game board, * Pain in the upper limb (VAS score\>3), * Contraindications to the use of botulinum toxins and absence of indications as mentioned in the HAS 2010 recommendations * Patients under legal protection (guardianship, curatorship, ...) * Refusal to participate
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| To study the sensitivity to change of the BE API 2.0 bimanual 3D analysis protocol by measuring the change in the severity of movement deviation in the upper limb before and after therapy | 2 months | The Arm Profile score is a kinematic index that reflects the severity of the subject's movement deviation compared to the normal deviation of healthy children. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| To measure the change induced by the therapy on the parameters measured in movement analysis (kinematic), clinical and functional measures at the deficient MS (comparison before and after therapy). | 2 months | kinematic parameters measured in motion analysis with the BE API 2.0 protocol |
| To measure the change induced by the therapy on the parameters measured in movement analysis (spatio-temporal), clinical and functional measures at the deficient MS (comparison before and after therapy). | 2 months | Spatio-temporal parameters measured in motion analysis with the BE API 2.0 protocol |
| To study the association between the parameters measured in motion analysis clinical/functional measurements (kinematics and spatio-temporal parameters) before and after therapy. | 2 months | Correlation of motion analysis measurements (kinematics and spatio-temporal parameters) measured with the BE API 2.0 protocol before and after therapy to clinical. |
| To study the association between the parameters measured in motion analysis with the BE API 2.0 protocol (kinematics and spatio-temporal parameters) before and after therapy. | 2 months | Correlation of motion analysis measurements (kinematics and spatio-temporal parameters) measured with the BE API 2.0 protocol before and after functional measurements |
| Compare the dominant and non-dominant upper limb of PC children on parameters measured in motion analysis with the BE API 2.0 protocol (kinematic and spatio-temporal), before and after therapy. | 2 months | Compare motion analysis measurements (kinematics and spatiotemporal parameters) of dominant and non-dominant MS measured with the BE API 2.0 protocol before and after therapy |
Countries
France
Contacts
Primary ContactMarine Cacioppo
Outcome results
None listed